EP4171572
DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.6.2021EP published:
21.5.2025EP application number:
21737779.5
EPO information:
European Patent Register
Max expiry date:
22.6.2041
Title in English:
DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIRLanguage of the patent:
English
Timeline
Today
23.6.2021EP application
21.5.2025EP Publication
Owner
Name:
VIIV Healthcare CompanyAddress:
Corporation Service Company 251 Little Falls Drive, Wilmington, Delaware 19808, US
Inventor
Name:
CONN, Ian PaulAddress:
Ware Hertfordshire SG12 0DP, GB
Name:
DAVIES, Mark RobertAddress:
Ware Hertfordshire SG12 0DP, GB
Name:
HEAFIELD, JoanneAddress:
Ware Hertfordshire SG12 0DP, GB
Name:
HOLTON, MichaelAddress:
Ware Hertfordshire SG12 0DP, GB
Name:
MORTIMER, NeilAddress:
Ware Hertfordshire SG12 0DP, GB
Priority
Number:
202009684Date:
25.6.2020Country:
GB
Classification
Categories:
A61K 31/5365, A61K 9/20, A61P 31/18, A61K 9/28